Selected research
Industry Research
Generic Nifedipine Controlled-release Tablets Industry Research Report 2026
Market perspective
The global Generic Nifedipine Controlled-release Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Generic Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Generic Nifedipine Controlled-release Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Generic Nifedipine Controlled-release Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Generic Nifedipine Controlled-release Tablets include Simcere, Shanghai Shyndec Pharma, Qingdao Baiyang Pharmaceutical, Hefei Cube Pharma, Nanjing Easeheal Pharma, Deyao Pharma, CR DOUBLE-CRANE, Beijing Honglin Pharma and Apichope, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Generic Nifedipine Controlled-release Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Generic Nifedipine Controlled-release Tablets Market by Company
Simcere
Shanghai Shyndec Pharma
Qingdao Baiyang Pharmaceutical
Hefei Cube Pharma
Nanjing Easeheal Pharma
Deyao Pharma
CR DOUBLE-CRANE
Beijing Honglin Pharma
Apichope
Generic Nifedipine Controlled-release Tablets Segment by Type
30mg per Tablet
60mg per Tablet
Generic Nifedipine Controlled-release Tablets Segment by Application
Hypertension
Exertional Angina
Other
Generic Nifedipine Controlled-release Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Generic Nifedipine Controlled-release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Generic Nifedipine Controlled-release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Generic Nifedipine Controlled-release Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Generic Nifedipine Controlled-release Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Generic Nifedipine Controlled-release Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Generic Nifedipine Controlled-release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 30mg per Tablet
- 60mg per Tablet
Applications
- Hypertension
- Exertional Angina
- Other
Companies covered
- Simcere
- Shanghai Shyndec Pharma
- Qingdao Baiyang Pharmaceutical
- Hefei Cube Pharma
- Nanjing Easeheal Pharma
- Deyao Pharma
- CR DOUBLE-CRANE
- Beijing Honglin Pharma
- Apichope
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Generic Nifedipine Controlled-release Tablets Market Size (2021-2032)
- 2.2.2 Global Generic Nifedipine Controlled-release Tablets Sales (2021-2032)
- 2.2.3 Global Generic Nifedipine Controlled-release Tablets Market Average Price (2021-2032)
- 2.3 Generic Nifedipine Controlled-release Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 30mg per Tablet
- 2.3.3 60mg per Tablet
- 2.4 Generic Nifedipine Controlled-release Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hypertension
- 2.4.3 Exertional Angina
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Generic Nifedipine Controlled-release Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Generic Nifedipine Controlled-release Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Generic Nifedipine Controlled-release Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Generic Nifedipine Controlled-release Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Generic Nifedipine Controlled-release Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Generic Nifedipine Controlled-release Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Generic Nifedipine Controlled-release Tablets, Product Type & Application
- 3.8 Global Manufacturers of Generic Nifedipine Controlled-release Tablets, Established Date
- 3.9 Global Generic Nifedipine Controlled-release Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Simcere
- 4.1.1 Simcere Company Information
- 4.1.2 Simcere Business Overview
- 4.1.3 Simcere Generic Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Simcere Generic Nifedipine Controlled-release Tablets Product Portfolio
- 4.1.5 Simcere Recent Developments
- 4.2 Shanghai Shyndec Pharma
- 4.2.1 Shanghai Shyndec Pharma Company Information
- 4.2.2 Shanghai Shyndec Pharma Business Overview
- 4.2.3 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
- 4.2.5 Shanghai Shyndec Pharma Recent Developments
- 4.3 Qingdao Baiyang Pharmaceutical
- 4.3.1 Qingdao Baiyang Pharmaceutical Company Information
- 4.3.2 Qingdao Baiyang Pharmaceutical Business Overview
- 4.3.3 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product Portfolio
- 4.3.5 Qingdao Baiyang Pharmaceutical Recent Developments
- 4.4 Hefei Cube Pharma
- 4.4.1 Hefei Cube Pharma Company Information
- 4.4.2 Hefei Cube Pharma Business Overview
- 4.4.3 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
- 4.4.5 Hefei Cube Pharma Recent Developments
- 4.5 Nanjing Easeheal Pharma
- 4.5.1 Nanjing Easeheal Pharma Company Information
- 4.5.2 Nanjing Easeheal Pharma Business Overview
- 4.5.3 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
- 4.5.5 Nanjing Easeheal Pharma Recent Developments
- 4.6 Deyao Pharma
- 4.6.1 Deyao Pharma Company Information
- 4.6.2 Deyao Pharma Business Overview
- 4.6.3 Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Deyao Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
- 4.6.5 Deyao Pharma Recent Developments
- 4.7 CR DOUBLE-CRANE
- 4.7.1 CR DOUBLE-CRANE Company Information
- 4.7.2 CR DOUBLE-CRANE Business Overview
- 4.7.3 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product Portfolio
- 4.7.5 CR DOUBLE-CRANE Recent Developments
- 4.8 Beijing Honglin Pharma
- 4.8.1 Beijing Honglin Pharma Company Information
- 4.8.2 Beijing Honglin Pharma Business Overview
- 4.8.3 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
- 4.8.5 Beijing Honglin Pharma Recent Developments
- 4.9 Apichope
- 4.9.1 Apichope Company Information
- 4.9.2 Apichope Business Overview
- 4.9.3 Apichope Generic Nifedipine Controlled-release Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Apichope Generic Nifedipine Controlled-release Tablets Product Portfolio
- 4.9.5 Apichope Recent Developments
5 Global Generic Nifedipine Controlled-release Tablets Market Scenario by Region
- 5.1 Global Generic Nifedipine Controlled-release Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021-2032
- 5.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021-2026
- 5.2.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2027-2032
- 5.3 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2027-2032
- 5.4 North America Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
- 5.4.1 North America Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
- 5.4.3 North America Generic Nifedipine Controlled-release Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
- 5.5.1 Europe Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Generic Nifedipine Controlled-release Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
- 5.7.1 South America Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
- 5.7.3 South America Generic Nifedipine Controlled-release Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032)
- 6.1.1 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Generic Nifedipine Controlled-release Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032)
- 7.1.1 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Generic Nifedipine Controlled-release Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Generic Nifedipine Controlled-release Tablets Value Chain Analysis
- 8.1.1 Generic Nifedipine Controlled-release Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Generic Nifedipine Controlled-release Tablets Production Mode & Process
- 8.2 Generic Nifedipine Controlled-release Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Generic Nifedipine Controlled-release Tablets Distributors
- 8.2.3 Generic Nifedipine Controlled-release Tablets Customers
9 Global Generic Nifedipine Controlled-release Tablets Analyzing Market Dynamics
- 9.1 Generic Nifedipine Controlled-release Tablets Industry Trends
- 9.2 Generic Nifedipine Controlled-release Tablets Industry Drivers
- 9.3 Generic Nifedipine Controlled-release Tablets Industry Opportunities and Challenges
- 9.4 Generic Nifedipine Controlled-release Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst